Clinical Trial Update: Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer [Phase 3]

View source ↗

Summary

This update covers a Phase 3 trial of gemcitabine in combination with ON-01910.Na for previously untreated metastatic pancreatic adenocarcinoma that has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• Gemcitabine (Gemcitabine)
• ON-01910.Na (ON-01910 sodium)

Snippet

Sponsor: Traws Pharma, Inc. | Conditions: Metastatic Pancreatic Adenocarcinoma | Phase 3 | Status: COMPLETED